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Abstract—This
work
explores
different
coupling
configurations (direct contact, air and water coupling) between a
single 915 MHz waveguide applicator and human tissue in the
setting of chest wall recurrence (CWR) of breast cancer. The
objective is to treat chest wall tumours with microwave
hyperthermia, while avoiding hot spots in critical areas such as
scars and ribs. The best coupling configuration was a customized
24×29 cm water bolus developed by our team. It helps the
applicator deliver an effective field size of 268 cm2 at 1 cm depth
and a penetration depth of 2-3 cm. Water bolus thickness can be
adjusted during treatment (0.5-4 cm) to shift hot spot locations
and thus homogenize thermal dose delivered over a 60 min
hyperthermia treatment. The virtual human chest model is easily
customized so it can be used as a tool for treatment planning and
quality assurance testing of microwave applicator configurations.
Index Terms—microwave antenna, chest wall recurrence,
treatment planning, breast cancer, hyperthermia.

I.

INTRODUCTION

The efficacy of adding superficial hyperthermia to
radiotherapy for chest wall recurrence (CWR) of breast cancer
has previously been established in randomized trials [1, 2].
However, a definite consensus towards appropriate treatment
delivery has not been achieved and existing clinical guidelines
are currently being redefined [3, 4]. This paper reviews the
critical elements in superficial hyperthermia treatments for
CWR, and presents a virtual human chest model to be used as
a tool for treatment planning and quality assurance testing of
different microwave applicator configurations.
The treatment planning of superficial microwave
hyperthermia treatments considers three main components:
applicator, coupling between applicator and tissue, and patient
disease. Typical microwave applicators for these treatments
operate either at 434 MHz (Europe) or 915 MHz (USA).
Single and array applicators have been explored [5-7], but for
clinical practice in the USA, only single waveguide applicators
have been approved. The most common coupling mechanism
is a water bolus. It consists of a flexible plastic bag filled with
circulating deionized water at a controlled temperature. It plays
a critical role since it homogenizes the radiation field and cools
the skin, diffusing superficial hot spots and allowing minor
adjustment of penetration depth. This becomes especially
useful for low perfusion tissues such as scars that are typical in
CWR and have reduced ability to dissipate heat. Several
parameters of the coupling bolus must be considered: dielectric
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Fig. 1. Transerve CT image of a female patient with CWR of breast cancer.

properties, temperature, flow rate, shape, size, and thickness
[3, 8, 9]. Finally, one must also account for human anatomy,
tissue thermophysical properties [10-14] including dynamic
temperature dependent blood perfusion [15, 16], and most
importantly patient tolerance.
In this work, three computational models are assessed to
evaluate different aspects of a superficial hyperthermia
treatment. The first replicates a muscle-like homogenous
phantom used to validate the computational model (model 1).
The second is similar to the first but with actual human muscle
properties (model 2). Finally, a “virtual human” test model is
developed for treatment planning, which includes typical scars
and tumours of CWR with different properties (model 3). In
this model, the target temperature for hyperthermia cancer
treatment is defined in the range 40-45°C [7].
II.

METHODS

A. Experimental setup
The applicator analysed in this study is a rectangular slabloaded waveguide with dimensions 17.4×23.6×19.6 cm
(MA120, BSD Medical Corporation, Salt Lake City, Utah).
The radiated fields produced by the antenna were measured
with a miniature three-axis electric field probe with 1 mm step
size (Model 8021 B SAR Probe, Narda Corp, Hauppauge, NY)
in a tank containing a liquid muscle-like phantom. The probe
provides linearized output voltage directly proportional to the
total electric field squared |E|2 which is proportional to the

TABLE I.
Tissue

(kg/m3)

ρ

Cp
(J/kg/K)

k
(W/m/K)

ωb
(kg/s/m3)

Qm
(W/m3)

s
(°C2)

ω1

Tcr
(°C)

εr

Skin (skin wet)

1109 [10]

3391 [10]

0.37 [10]

0.97×F(T) [10]

1827 [10]

9.2 [15]

10 [15]

44 [15]

46.0 [13]

0.85 [13]

911 [10]

2348 [10]

0.21 [10]

0.52×F(T) [10]

461 [10]

1.0 [15]

12 [15]

45 [15]

5.5 [13]

0.05 [13]

1090 [10]

3421 [10]

0.49 [10]

0.75×F(T) [10]

1052 [10]

7.9 [15]

12 [15]

45 [15]

55.0 [13]

0.95 [13]

Property

Subcutaneous fat
Muscle
Lung

a
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σ

(S/m)

722 [10]

3886 [10]

0.39 [10]

5.06×F(T) [10]

4483 [10]

7.9 [15]

12 [15]

45 [15]

36.7 [13]

0.66 [13]

Rib

1543 [10]

1793 [10]

0.32 [10]

0.48×F(T) [10]

421 [10]

1.0 [15]

12 [15]

45 [15]

16.6 [13]

0.24 [13]

Scar (skin dry)

1109 [10]

3391 [10]

0.37 [10]

-

-

-

-

-

41.3 [13]

0.87 [13]

Blood

1050 [10]

3617 [10]

0.52 [10]

-

-

-

-

-

61.3 [13]

1.54 [13]

Low ωb tumour

1090 [10]

3421 [10]

0.49 [10]

0.58×F(T) [12]

1225 [12]

2.0 [16]

12 [16]

43 [16]

51.3 [14]

0.89 [14]

High ωb tumour

1090 [10]

3421 [10]

0.49 [10]

1.91×F(T) [12]

2267[12]

2.0 [16]

12 [16]

43 [16]

56.3 [14]

0.97 [14]

Adenocarcinoma

1090 [10]

3421 [10]

0.49 [10]

7.63×F(T) [11]

3754 [12]

2.0 [16]

12 [16]

43 [16]

60.0 [14]

1.07 [14]

a

Muscle phantom

1097

3083

0.31

-

-

-

-

-

46

1.26a

De-ionized water

992

4176

0.63

-

-

-

-

-

79a

0.18a

measured.

specific absorption rate SAR = σE2/2ρ, where σ is the electrical
conductivity and ρ the density of the phantom, respectively.
This fluid phantom is a standard mixture of ethylene glycol
and saline which matches the dielectric properties of muscle at
915 MHz: 70% laboratory grade ethylene glycol, 28% distilled
water and 2% non-iodized table salt (properties on Table I).
B. Computational model
All models include the complete structure of the slabloaded waveguide applicator, using σ = 4.75 for the packed
crystalline sodium chloride chambers against the sidewalls.
The load dimensions of models 1 (phantom) and 2 (muscle)
are 35×44×13 cm and the thermophysical properties are
presented in Table I. Model 3 consists of a mixture of tumour,
skin, blood, necrotic tissue as well as adipose and
fibroconnective tissues typical of CWR (Fig. 1). The
thermophysical and biological properties of this heterogeneous
tissue vary by several orders of magnitude [11, 14, 17]. Fig. 2
shows the multi-layer model 3, which includes 1.5 mm skin, 8
mm fat, 1 cm muscle, 9 cm lung and 3 ribs (bone) located 1
mm above the lung in the muscle region. This model also
includes two scars (0.35×10×1 cm) running perpendicular and
parallel to the electric field (E-field) and three distinct tumours.
Many different tumour geometries can be considered in CWR,
including carcinomas, melanomas, and even some lymphomas.
Many are diffuse disease involving skin while others are
discrete nodules. Therefore, we account for one
adenocarcinoma as seen in Fig. 1 (cylinder with 1.5 cm radius
and height) and two elliptically shaped chest wall tumours
(3x5x1.5 cm) – Tumour L and Tumour H with low and high
blood perfusion, respectively. The thermophysical properties
for all tissue regions are given in Table I.
The E-field and temperature are calculated in COMSOL
Multiphysics (COMSOL, Palo Alto, CA) – a finite element
software – to solve the combined bioheat transfer equation and
Maxwell equations [17]. The bioheat equation consists of an

extended version of the classic heat equation with a heat sink
due to blood perfusion (ωb), an internal heat source due to
metabolism (Qm) and an external heat source due to absorption
of microwave energy derived from the applicator (ρSAR). The
electro-thermal model is meshed with manual settings, where
the maximum mesh element size of each object is λair/sqrt(ε)
with λair the wavelength in air and ε the dielectric constant of
the meshed object. The resulting model consists of
approximately 1×106 tetrahedral elements. All simulations are
performed for an operating frequency of 915 MHz. The
cooling bolus is embodied in a Robin boundary condition with
variable Tbolus and fixed hbolus = 85 W/m2/K [3]. In the top and
lateral surfaces, we impose a similar boundary condition due to
air cooling with Tair = 25°C and hair = 5 W/m2/K. At the
bottom surface we impose a core temperature of Tcore = 37°C.

Fig. 2.
Model 3 – virtual human chest model with 1.5 mm skin, 8 mm fat,
2 cm muscle, and 10 cm lung thicknesses. Lateral dimensions are 36×44 cm.
Waveguide aperture dimensions are 17.4×23.6 cm. Tumor L and Tumour H
correspond to low and high blood perfusion tumours, respectively.

Direct contact

BSD bolus
19.4×27.6×3 cm

3cm air

Custom bolus
24×29×3 cm

1

0.5
Fig. 4.
Normalized SAR pattern at 5 mm depth in model 1 for four
applicator configurations. The external white frame corresponds to the
waveguide boundaries: 17.4×23.6 cm.

Fig. 3.
Experimental (A) and simulated (B) SAR pattern at 5 mm depth in
model 1 for 3 cm air coupling between applicator and liquid muscle phantom.

Finally, we account for thermoregulation. Blood perfusion,
in particular, plays a critical role in hyperthermia treatments
since it is a dynamic heat sink that varies with temperature [15,
16]. To account for this thermoregulatory effect, we included a
temperature-dependent scaling function given by:
2⎞
⎧
⎛
⎪⎪1 + ω1 exp ⎜ − (T − Tcr ) ⎟ , T ≤ Tcr
⎜
⎟
F (T ) = ⎨
s
⎝
⎠
⎪
, T > Tcr
⎪⎩1 + ω1

(1)

where ω1 and s are curve fitting parameters derived from
experimental data; and Tcr is a critical temperature that is
tissue-specific (Table I).
C. Parametric studies
SAR patterns of the MA120 applicator were measured and
simulated at a depth of 5 mm in model 1 for four different
coupling configurations: direct contact; 3 cm air coupling and
no water bolus; BSD water bolus (19.4×27.6×3 cm), which
integrated in a teflon frame; and a custom water bolus bag
(24×29×3 cm). Water flow was approximately 3.6 l/min as
controlled with the BSD 500 water conditioning system (BSD
Medical Corporation, Salt Lake City, Utah). For
characterization purposes, we chose to determine the effective
field size (EFS) that is the area of the 50% SAR contours
measured at 1 cm depth, and the penetration depth (PD) that is
the distance below 1 cm at which SAR falls to 50% of that at 1
cm [5]. In model 2, the EFS and PD were determined for
several different thickness of water and air coupling: 5, 13, 20,
30 and 40 mm.
III.

RESULTS

A. Experimental validation of computational model
The experimental SAR results were measured and
normalized in a plane 5 mm deep in the phantom. Simulations
of all configurations in the matching model 1 are in good
agreement with the measured SAR patterns. The 3 cm air gap
configuration is shown in Fig. 3 as an example.
In Fig. 4, simulations of both direct contact and air
coupling configurations show a Gaussian-like pattern, with
50% SAR areas of 18×18 cm2 and 13×22 cm2, respectively.

The use of a water bolus improves coupling between applicator
and tissue. Both water boluses present a similar field size at 5
mm depth of approximately 16×16 cm2. However, the use of a
larger water bolus bag produces a more homogennous SAR
pattern that is desirable for superficial hyperthermia treatment.
B. Characterization of different applicator configurations
The penetration depth and effective field size at 1 cm depth
in model 2 are presented in Table II. The average PD is 2 cm
and it is higher for water coupling due to improved impedance
matching. Increasing the separation between applicator and
muscle load decreases EFS for both air and water coupling.
However, for water boluses thicker than 1 cm there is a nonlinear behaviour, explained by SAR perturbations arising due
to resonance inside the bolus [8]. Although the EFS of air
coupling is higher, its centrally peaked SAR pattern is less
desirable for treatment of large area CWR (Fig. 4).
C. Heating of virtual human chest wall test phantom
In Fig. 5, we present the range of volume (dark green) and
surface (light green) temperatures as well as SAR distribution
(blue) for each tissue region. The following setup is typical in
our clinic: bolus temperature = 42°C; bolus thickness = 13 mm
(Fig. 5A) or 30 mm (Fig. 5B); input power = 160 W. The
advantage of presenting both temperature and SAR together is
that it emphasizes the impact on temperature increase of the
quite different power deposition and thermal properties of the
various tissue regions. For instance, the two tumours that differ
only in blood perfusion absorb a similar SAR range, but
TABLE II.
PENETRATION DEPTH AND EFFECTIVE FIELD SIZE FOR
SEVERAL WATER AND AIR SEPARATIONS BETWEEN APPLICATOR AND SKIN.
Thickness
(mm)

EFS (cm2)

PD (cm)
Water

Direct contact

Air

Water

2.3

Air
311

5

2.1

2.0

293

401

9

2.0

1.8

283

371

13

2.0

1.9

281

344

20

2.1

1.9

266

305

30

1.9

1.9

245

287

40

2.0

1.9

240

278

BSD bolus (30mm)

1.6

-

264

-

A
47

40.6

39.6 38.4

38.7

Temperature T90
37.1 40.3 41.5

38.5

40.3

42.0

600

400

41

300

SAR (W/kg)

500
43

200
39

100

37

Volume temperature

B
47
45

40.6

39.5 38.3

38.6

Surface temperature

Temperature T90
37.1 40.0 41.2

38.5

0

Fig. 6. Transverse plane of SAR pattern across human chest wall model 3.

500

The effect of constructive interference due to reflections at
the sharply contrasting rib/muscle dielectric interfaces can be
observed in Fig. 6. In this model, SAR from the 915 MHz field
does not cause overheating of surface tissues since the ribs are
2.5 cm deep. For mastectomy patients that often have less than
1-1.5 cm tissue overlying the ribs, hot spots may result above
and between the ribs.

SAR
40.5

41.9

450
400
350

43

300

41

250
200
150

39

100

37

50
0

SAR (W/kg)

Temperature (°C)

45

Temperature (°C)

700

Fig. 5.
Temperature and SAR distribution for all tissues in model 3 with
Tbolus = 42°C, bolus thickness = 13 mm (A) and 30 mm (B); antenna power
= 160 W (Tumor H = tumor with high blood perfusion; Tumor L =tumor
with low blood perfusion; Scar PL = parallel scar; Scar PR = perpendicular
scar). Muscle, skin, fat and rib temperatures are taken from the effective
heating volumes limited by the waveguide boundaries (17.4×23.6 cm). T90
is presented above the graph.

have a 4°C difference in maximum temperature. The
adenocarcinoma absorbs even more energy (higher SAR) due
to possible resonance effects within its 1.5 cm structure.
However, this did not produce tumour temperatures in the
desired 40-45°C range (shaded) due to the very high perfusion
(7.63 kg/s/m3) which represents a worst case of tissue
properties [11]. Nonetheless, the two large tumours (L and H)
were the primary targets for the treatment since they are
centered in the applicator. These tumours achieve a T90 of
41.5°C (tumour L) and 40.3°C (tumour H) for 13 mm bolus
thickness, meaning that 90% of the tumour exceeds the T90
temperature [17]. The remaining 10% of tumor absorbs less
energy as the SAR pattern falls off rapidly at the tumor edges.
In Fig. 5, separate reporting of surface temperate range
(light green) enhances understanding of deeper temperatures in
the same tissue regions. In the clinic, eight measurements are
typically collected per treatment. Due to the cooling effect of
the bolus and higher power deposition at the surface, the
temperature differentials are significant. They range from 1°C
(adenocarcinoma) to 4.3°C (tumour H) in terms of surface
temperature, but can reach 7°C (tumour L) in terms of volume
temperature differential.

IV.

DISCUSSION

In this work, we validate a new treatment planning model
for the BSD MA120 waveguide applicator and characterize
four applicator/bolus setups for superficial CWR treatments.
Current tools allow segmentation of patient-specific
anatomical models [18], but these are time consuming and not
yet practical for routine planning. We use a virtual human
chest wall model as a tool for quick assessment of different
treatment configurations. The model includes all structures
typical of chest wall recurrence, and is easily customized.
Although this study addresses a single applicator, it
illuminates several mechanisms available to adjust temperature
distribution under a microwave applicator. The air coupling
was implemented since it is relevant in some extreme cases,
where patients present open wounds with active bleeding and
are intolerant to pressure. However, the use of water bolus is
always preferable in order to control skin temperature.
In Fig. 5, temperature and SAR distributions are presented
for different bolus thicknesses. By increasing the thickness
from 13 mm to 30 mm, the maximum temperatures of healthy
tissues decrease up to 0.7 °C while maintaining tumours T90
within the range 40-45°C. In practice, when placed on a
contoured chest, the bolus thickness can reach 4-5 cm at its
borders, while in the centre it may be less than 1 cm thick.
Clearly, variations in bolus thickness contribute to hot spots,
but those hot spots can be shifted around under the aperture as
shown in Fig. 4 to homogenize thermal dose delivered over a
60 min treatment.
The development of hot spots is unavoidable in HT
treatment, and in extreme cases might lead to pain and blisters.
Overheating may occur at bone/muscle and fat/muscle
interfaces, and in poorly perfused tissues such as scars, grafts
and the interior of necrotic tumours. The scars of model 3,
which run parallel and perpendicular to the electric field,
demonstrate that power absorption and tissue temperature are
very different, even though both scars are located within the

50% SAR contour. In fact, parallel orientation produces
preferential heating of scar tissue, suggesting rotation of the
applicator to avoid preferential accumulation of heat in the
scars.
In this work we accounted for tissue-specific temperature
dependent perfusion. Without this effect, only 60 W were
required to heat the model 3 tumour target regions into the
desired 40-45°C range. However, after accounting for
thermoregulation, the heat dissipation increased and more
power was required. The power used to obtain the distributions
in Figs. 5 and 6 was 160 W, which agrees with the 120-180 W
range used clinically for the MA120.
Finally, penetration depth is a parameter that has different
definitions in the literature. If we apply the definition
traditionally used in hyperthermia [5], the penetration depth is
about 2 cm for different applicator configurations (Table II).
However, others have defined PD as the depth at which the
SAR becomes 1/e2 of its value at the surface. In this case the
effective PD is 3 cm, which is consistent with 3 cm deep
tissues (lung) reaching 40°C (Fig. 5). Ultimately, the
temperature and consequently thermal dose distribution is what
is most relevant clinically [7, 17]. The relevance of
temperature is sometimes embodied in T90, which is useful to
quantify the temperature distribution. However, thermal
modeling assessment of complete temperature ranges for all
tissues is a valuable tool to predict the location of hot spots and
thus improve treatment quality.
In summary, the virtual human chest wall model facilitates
instructive treatment planning that can be easily adjusted to
model individual anatomies, such as different thicknesses and
depths of fat, scars, tumours and ribs. In our clinic, the
majority of patients present disease dispersed within the top 12 cm. Deeper tumours can also be heated by increasing input
power and decreasing the bolus temperature [3].
V.

CONCLUSIONS

A simplified 3D computer model was developed for the
study of superficial hyperthermia treatments with a single
microwave waveguide applicator. All clinically relevant
structures were included in the model. Although single
waveguide applicators are fairly simple, there are several
parameters that can be adjusted to minimize hot spots that
cause pain and blisters. While heating pattern peaks are
unavoidable, they can be shifted during treatment by varying
bolus temperature and thickness. The custom water bolus bag
demonstrated better performance than the teflon frame bolus
supplied with the applicator. The proposed temperature and
SAR range analysis facilitates rapid global assessment of
CWR treatment quality. The presented simplified computer
model can then be integrated in routine treatment planning into
quality assurance (QA) practice for improved therapy in the
clinic.
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